← Back to Search

Behavioral Intervention

Maternal Mental Health Access for Postpartum Depression (MaMa Trial)

N/A

Recruiting

Led By Gwen Latendresse

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18+ years of age, who at the time of screening

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6, 12 & 18 months)

Awards & highlights

MaMa Trial Summary

This trial will evaluate an Evidence-Based Intervention (EBI) to help at-risk pregnant & postpartum women; targeting diverse populations. The team will assess implementation feasibility & acceptability using existing patient portals & refine protocol for future studies.

Who is the study for?

This trial is for pregnant or postpartum women (up to 1 year after birth) who are at least 18 years old, speak English or Spanish, and attend certain clinics. They must be at risk for postpartum depression but not have severe mental health conditions like psychosis or bipolar disorder, substance use disorders, severe anxiety, suicidality, or be on current mental health medications.Check my eligibility

What is being tested?

The study tests a remote-access maternal mental health intervention that includes On-Demand content plus Video Conferencing (VC), and another with On-Demand content plus a Discussion Board (DB). It aims to prevent postpartum depression among diverse populations in different settings.See study design

What are the potential side effects?

Since the interventions involve non-medical treatments such as video conferences and discussion boards designed to support mental health, traditional medication side effects are not expected. However, participants may experience emotional discomfort when discussing personal issues.

MaMa Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

MaMa Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6, 12 & 18 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6, 12 & 18 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6, 12 & 18 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Implementation outcome; Feasibility and acceptability

Secondary outcome measures

Sociocultural Determinants and Behavior

Other outcome measures

Exploratory analysis of patient symptom

Implementation Outcome; Patient engagement

MaMa Trial Design

3Treatment groups

Experimental Treatment

Group I: Choice 3Experimental Treatment3 Interventions

Options; Om-Demand (OD) or On-Demand (OD) + Video Conference (VC)

Group II: Choice 2Experimental Treatment3 Interventions

Options: On-Demand (OD) + Discussion board (DB) or OD + Video Conference (VC)

Group III: Choice 1Experimental Treatment2 Interventions

Options; On-Demand (OD) alone or On-Demand (OD) with a facilitated discussion board (DB)

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Arm 3

2020

N/A

~930

Arm 2

2020

N/A

~1180

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor

1,102 Previous Clinical Trials

1,779,141 Total Patients Enrolled

National Institute of Nursing Research (NINR)NIH

580 Previous Clinical Trials

10,376,441 Total Patients Enrolled

1 Trials studying Postpartum Depression

287 Patients Enrolled for Postpartum Depression

Gwen LatendressePrincipal InvestigatorUniversity of Utah

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies remaining for participants in this investigation?

"Affirmative. Clinicaltrials.gov data reveals that the trial, which was originally posted on April 4th 2023 and most recently revised on September 20th 2023, is actively seeking participants. At present, 120 individuals need to be recruited from a single clinical site."

Answered by AI

What is the current participation capacity for this research initiative?

"Indeed, the information on clinicaltrials.gov confirms that this medical trial is actively recruiting participants. This investigation was first posted on April 4th 2023 and updated most recently on September 20th of the same year. A total of 120 volunteers will be necessary to complete trials at a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Maternal Mental Health Access - MaMa

Gwen Latendresse 2023. "Maternal Mental Health Access - MaMa". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06049433.